ReviewCancers2024

Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies.

Hina Amer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.